Cargando…

Systemic Profiling of KDM5 Subfamily Signature in Non-Small-Cell Lung Cancer

BACKGROUND: Despite improvements in diagnosis and treatment, lung cancer is one of the most lethal human diseases, with a dismal 5-year relative survival rate of only 5% for patients diagnosed with advanced metastatic disease. Accumulating evidence supports that epigenetic aberration of histone deme...

Descripción completa

Detalles Bibliográficos
Autor principal:	Hao, Fang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8558507/ https://www.ncbi.nlm.nih.gov/pubmed/34737620 http://dx.doi.org/10.2147/IJGM.S329733

Ejemplares similares

Systematic analysis of JmjC gene family and stress-response expression of KDM5 subfamily genes in Brassica napus
por: He, Xinghui, et al.
Publicado: (2021)

EZH2 and KDM6B Expressions Are Associated with Specific Epigenetic Signatures during EMT in Non Small Cell Lung Carcinomas
por: Lachat, Camille, et al.
Publicado: (2020)

Identification of the KDM2/7 Histone Lysine Demethylase Subfamily Inhibitor and its Antiproliferative Activity
por: Suzuki, Takayoshi, et al.
Publicado: (2013)

Epigenetic Suppression of the T-box Subfamily 2 (TBX2) in Human Non-Small Cell Lung Cancer
por: Nehme, Eliana, et al.
Publicado: (2019)

Long non‐coding RNA KDM5B anti‐sense RNA 1 enhances tumor progression in non‐small cell lung cancer
por: Lou, Baisong, et al.
Publicado: (2019)

Transcriptomic and Drug Discovery Analyses Reveal Natural Compounds Targeting the KDM4 Subfamily as Promising Adjuvant Treatments in Cancer
por: del Moral-Morales, Aylin, et al.
Publicado: (2022)

KDM1A promotes tumor cell invasion by silencing TIMP3 in non-small cell lung cancer cells
por: Kong, Lingzhi, et al.
Publicado: (2016)

Mutations in KMT2C, BCOR and KDM5C Predict Response to Immune Checkpoint Blockade Therapy in Non-Small Cell Lung Cancer
por: Liu, Dingxie, et al.
Publicado: (2022)

Histone demethylase JARID1B/KDM5B promotes aggressiveness of non-small cell lung cancer and serves as a good prognostic predictor
por: Kuo, Kuang-Tai, et al.
Publicado: (2018)

Histone demethylase KDM6A coordinating with KMT2B regulates self-renewal and chemoresistance of non-small cell lung cancer stem cells
por: Chen, Zhiwei, et al.
Publicado: (2023)

The immune response‐related mutational signatures and driver genes in non‐small‐cell lung cancer
por: Chen, Hao, et al.
Publicado: (2019)

Protein Complex Interactor Analysis and Differential Activity of KDM3 Subfamily Members Towards H3K9 Methylation
por: Brauchle, Michael, et al.
Publicado: (2013)

Alcohol‐associated fibrosis in females is mediated by female‐specific activation of lysine demethylases KDM5B and KDM5C
por: Schonfeld, Michael, et al.
Publicado: (2022)

Small nucleolar RNA signatures as biomarkers for non-small-cell lung cancer
por: Liao, Jipei, et al.
Publicado: (2010)

Transient Receptor Potential Cation Channel Subfamily V Member 1 Expression Promotes Chemoresistance in Non-Small-Cell Lung Cancer
por: Li, Li, et al.
Publicado: (2022)

A Screening of Epigenetic Therapeutic Targets for Non-Small Cell Lung Cancer Reveals PADI4 and KDM6B as Promising Candidates
por: Lesbon, Jéssika Cristina Chagas, et al.
Publicado: (2022)

The emerging role of KDM5A in human cancer
por: Yang, Guan-Jun, et al.
Publicado: (2021)

Small molecule KDM4s inhibitors as anti-cancer agents
por: Lin, Hongzhi, et al.
Publicado: (2018)

Targeting of KDM5A by miR-421 in Human Ovarian Cancer Suppresses the Progression of Ovarian Cancer Cells
por: Ren, Fang, et al.
Publicado: (2020)

An 8-Gene Signature for Classifying Major Subtypes of Non-Small-Cell Lung Cancer
por: Hamaneh, Mehdi, et al.
Publicado: (2022)

Gene Expression Profiles from Needle Biopsies Provide Useful Signatures of Non-Small Cell Lung Carcinomas
por: Paull, Douglas E., et al.
Publicado: (2007)

The KDM5A/RBP2 histone demethylase represses NOTCH signaling to sustain neuroendocrine differentiation and promote small cell lung cancer tumorigenesis
por: Oser, Matthew G., et al.
Publicado: (2019)

The long non-coding RNA SNHG4/microRNA-let-7e/KDM3A/p21 pathway is involved in the development of non-small cell lung cancer
por: Wang, Fan, et al.
Publicado: (2020)

Identification of Serum Peptidome Signatures of Non-Small Cell Lung Cancer
por: Klupczynska, Agnieszka, et al.
Publicado: (2016)

Molecular gene signature and prognosis of non-small cell lung cancer
por: Huang, Poyin, et al.
Publicado: (2016)

Frontiers of MicroRNA Signature in Non-small Cell Lung Cancer
por: Zhu, Xinping, et al.
Publicado: (2021)

Epigenetic Regulation by Lysine Demethylase 5 (KDM5) Enzymes in Cancer
por: Blair, Lauren P., et al.
Publicado: (2011)

Circulating tumor cell methylation profiles reveal the classification and evolution of non-small cell lung cancer
por: Jiang, Jia-Hao, et al.
Publicado: (2022)

KDM5C Expedites Lung Cancer Growth and Metastasis Through Epigenetic Regulation of MicroRNA-133a
por: Zhang, Quan, et al.
Publicado: (2021)

Targeting of Histone Demethylases KDM5A and KDM6B Inhibits the Proliferation of Temozolomide-Resistant Glioblastoma Cells
por: Romani, Massimo, et al.
Publicado: (2019)

The EP300, KDM5A, KDM6A and KDM6B Chromatin Regulators Cooperate with KLF4 in the Transcriptional Activation of POU5F1
por: Wang, Wan-Ping, et al.
Publicado: (2012)

The methylation profiles of PRDM promoters in non–small cell lung cancer
por: Tan, Shuang-xiang, et al.
Publicado: (2018)

Molecular profile of non-small cell lung cancer in northeastern Brazil
por: de Oliveira, Ana Claudia da Silva Mendes, et al.
Publicado: (2019)

Extracellular RNA profiles in non-small cell lung cancer plasma
por: Ni, Yaojun, et al.
Publicado: (2023)

Histone Lysine Demethylases KDM5B and KDM5C Modulate Genome Activation and Stability in Porcine Embryos
por: Glanzner, Werner Giehl, et al.
Publicado: (2020)

KDM5A and KDM5B histone-demethylases contribute to HU-induced replication stress response and tolerance
por: Gaillard, Solenne, et al.
Publicado: (2021)

Drawing a line between histone demethylase KDM5A and KDM5B: their roles in development and tumorigenesis
por: Yoo, Jung, et al.
Publicado: (2022)

Diverse Functions of KDM5 in Cancer: Transcriptional Repressor or Activator?
por: Ohguchi, Yasuyo, et al.
Publicado: (2022)

Integrative Analysis for Identification of Therapeutic Targets and Prognostic Signatures in Non-Small Cell Lung Cancer
por: Erkin, Özgür Cem, et al.
Publicado: (2022)

Molecular profiling of non-small cell lung cancer
por: Forsythe, Marika L., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8ke6nfeqfjmak3uir0gmca2d1i